×

Dr. MV Frias is elected to US-NIH’s ACTG Executive Committee

April 12, 2021 | 8:53 am

Dr. MV Frias is elected to US-NIH’s ACTG Executive Committee

Dr. Melchor Victor Frias IV, the former DLSMHSI vice chancellor for Research, has been elected investigator-at-large of the AIDS Clinical Trials Group (ACTG) of the United States – National Institute of Health (NIH). The investigator-at-large is nominated by the general membership of the ACTG and is elected by ballot by its voting members. As investigator-at-large, Dr. Frias becomes a member of the ACTG’s Executive Committee (AEC), which serves as the main governing body of the ACTG network and is responsible for the development and implementation of policy, procedural decisions, and resource allocation for the ACTG.

As a member of the AEC, Dr. Frias will participate in discussions and processes towards the development of the ACTG to help it achieve its objectives.

The ACTG is the world’s largest and longest running HIV clinical trials network and seeks to “advance approaches to ultimately cure HIV” tuberculosis, viral hepatitis and its co-morbidities by conducting and supporting groundbreaking research all over the world.